×
<- Back

Exercise & Chemotherapy-Induced Neuropathy Webinar

Speciality Classification
Physiotherapists
Start Date
20-Aug-2021
Location
Online
End Date
20-Aug-2021
Delivery
Online
Duration
1.5 hours
Provider
Exercise & Sports Science Australia

Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating neurological side-effect of numerous cancer therapies included in breast, colorectal, prostate, gynaecological and haematological cancer treatments. CIPN is common and can occur in up to three-quarters of patients ranging from mild to severe symptoms, with severe symptoms potentially leading to reduced treatment doses. The main symptoms of CIPN include tingling and numbness, presenting in the hands and feet, which can be accompanied with altered sensation and pain. CIPN can occur during treatment and generally resolves within 6-12 months post-treatment. However, for some patients, symptoms present after cessation of treatment and among a smaller proportion CIPN symptoms may be permanent.

CIPN can also contribute to functional deficits, including changes in gait, reduced stability and balance issues. Considering many patients receiving cancer treatment may already be a falls risk due to being older, reduced feet sensation and impaired mobility impairing their balance is a critical problem. CIPN can impair fine motor skills and is a significant cause of reduced quality of life. There are no preventative or treatment agents to treat CIPN, however exercise has been suggested as a potential intervention to manage the functional deficits associated with CIPN.

Presented by Dr David Mizrahi BExPhys, BSc, PhD, MESSA, AEP

Dr David Mizrahi is an Accredited Exercise Physiologist who specialises in 'exercise-oncology' research. David completed his PhD at the University of New South Wales and Sydney Children’s Hospital in childhood cancer, and also completed a MSc investigating ovarian cancer. David is currently a Clinical Research Officer at the In Focus research group at UNSW investigating chemotherapy-induced peripheral neuropathy and from later 2021 will be time abroad as a Fulbright Scholar investigating exercise for children's cancers with St. Jude Children’s Research Hospital.

Schedule

Friday, 20 August 2021

12:00pm - 1:30pm  AEST

Please note, the times listed are in Australian Eastern Savings Time.

Your local time will be:

  • ACT:   12:00pm - 1:30pm
  • NSW:  12:00pm - 1:30pm
  • NT:     11:30am - 1:00pm
  • QLD:   12:00pm - 1:30pm
  • SA:      11:30am - 1:00pm
  • TAS:    12:00pm - 1:30pm
  • VIC:     12:00pm - 1:30pm
  • WA:     10:00am - 11:30pm

Please note: This is a live webinar and needs to be watched at the specified time above. If you are unable to watch the webinar live, it will be produced as podcast and can be purchased within the following month.

Rates per person

  • ESSA Member   $30.00
  • Non-Member    $50.00
  • ESSA Student Member  $15.00
  • Student Non-Member   $25.00

Please see terms & conditions for registration type definitions.

Access to Webinar

You will be provided information on how to access this webinar within your registration confirmation email.

NB: A confirmation of your attendance is required.

Target Audience

Any Accredited Exercise Physiologists.    

Type
Delivery
Title
Exercise & Chemotherapy-Induced Neuropathy Webinar
Location
Provider Type
Education Provider
Duration
1.5 hours
Start Date
20-Aug-2021
End Date
20-Aug-2021
CPD Points
1.5
Price
50.00
Price Details
ESSA Member $30.00 / Non-Member. $50.00 / ESSA Student Member $15.00 / Student Non-Member $25.00
Location
Online
Price:
$50.00
ESSA Member $30.00 / Non-Member. $50.00 / ESSA Student Member $15.00 / Student Non-Member $25.00
Similar Listings
HealthcareLink